Reform at the FDA-In Need of Reform
JAMA
.
2020 Jan 14;323(2):123-124.
doi: 10.1001/jama.2019.20538.
Author
Joshua M Sharfstein
1
Affiliation
1
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
PMID:
31935012
DOI:
10.1001/jama.2019.20538
No abstract available
Publication types
Editorial
Comment
MeSH terms
Drug Approval*
United States
United States Food and Drug Administration